OakChart

ProMIS Neurosciences Inc

PMNHealthcare·Biotechnology·Canada·Nano·NASD·Nov 11 • 1:00 PM ET

3.88-0.10 (-2.51%)
2026-11-11 19:03 CET
Market cap
35.69 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-42.23 USD m
Free cash flow, TTM
-41.90 USD m
EPS diluted, TTM
-13.43
P/E
-
Compare

Price

PMN against its 20, 50 and 200-day averages
2050200beatmissearnings
5.0010.0015.001.8M3.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PMNclose 3.8820-day 6.6250-day 9.58200-day 12.693.8852w low

85.8% under the 52-week high of 27.40 on 5 Mar 2026. 52-week low 2.78 on 2 Nov 2026. Last 15 sessions, 323.0% high to low

Profile

PMN
52-week range, 4% of the way up
2.7827.40

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Employees11
IPOJan 16, 2007
Beta-0.25
ATR, 14d1.12
Rel volume0.46
Short float3.91%
Insider own21.59%
Inst own60.67%

Snapshot

6 groups

Valuation

Index-
Market Cap34.79M
Enterprise Value-18.67M
Income-42.23M
Sales0.00M
Book/sh5.51
Cash/sh5.96
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees11
IPOJan 16, 2007

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.70
P/C0.65
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio7.85
Current Ratio7.85
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-13.43
EPS next Y-3.67
EPS next Q-1.28
EPS this Y77.43%
EPS next Y28.12%
EPS next 5Y46.96%
EPS past 3/5Y27.86% -0.39%
Sales past 3/5Y- -
EPS Y/Y TTM-169.38%
Sales Y/Y TTM-
EPS Q/Q82.32%
Sales Q/Q-
EarningsNov 12 AMC
EPS/Sales Surpr.7.15% -

Ownership

Insider Own21.59%
Insider Trans2.11%
Inst Own60.67%
Inst Trans0.76%
ROA-127.57%
ROE-172.30%
ROIC-85.48%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-41.42%
SMA50-59.50%
SMA200-69.41%
Trades-

Technical

Shs Outstand8.97M
Shs Float7.03M
Short Float3.91%
Short Ratio1.84
Short Interest0.27M
52W High27.40 -85.84%
52W Low2.78 39.56%
Volatility12.75% 21.82%
ATR (14)1.12
RSI (14)32.48
Beta-0.25
Rel Volume0.46
Avg Volume149.41K
Volume39,314

Performance

Perf Week10.23%
Perf Month-55.20%
Perf Quarter-73.77%
Perf Half Y-63.29%
Perf YTD-43.15%
Perf Year-60.71%
Perf 3Y-89.11%
Perf 5Y-98.15%
Perf 10Y-97.17%
Recom1.00
Target Price42.58
Prev Close3.98
Price3.88
Change %-2.51%

Analyst ratings

latest 1 of 1
DateActionAnalystRating changeTargetImplied
Jul 27, 2026InitiatedCChardan Capital MarketsBuy$20+415.5%

Peers

Mkt cap
TickerCompanyMkt cap
ABOSAcumen Pharmaceuticals Inc16.50M
ACIUAC Immune SA234.08M
CGTXCognition Therapeutics Inc64.66M
ANVSAnnovis Bio Inc35.83M
AVXLAnavex Life Sciences Corp102.43M
INMBINmune Bio Inc35.29M
PRTAProthena Corp Plc441.35M
ALECAlector Inc413.13M
BIVIBioVie Inc13.94M
ALZNAlzamend Neuro Inc6.22M

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Williams EugeneDirectorNov 04 '26Buy3.4326,50090,89540,213Nov 06 08:15 AM
Williams EugeneDirectorOct 30 '26Buy3.991,3165,25113,713Nov 03 08:28 AM
Cashman NeilChief Scientific OfficerNov 02 '26Buy3.8610,00038,60014,532Nov 03 08:26 AM
Kaplan JohanneChief Development OfficerAug 05 '26Buy13.302,28030,3246,221Aug 07 04:00 PM
Kirwin Patrick D.DirectorApr 22 '26Buy11.334,00045,3204,653Apr 23 09:25 PM
Williams EugeneDirectorMar 05 '26Buy24.402,00048,80012,397Mar 06 07:28 AM
Williams EugeneDirectorMar 04 '26Buy24.002,00048,00010,397Mar 04 06:08 PM
Williams EugeneDirectorMar 02 '26Buy22.531,00022,5307,397Mar 04 06:08 PM
Williams EugeneDirectorMar 03 '26Buy21.891,00021,8908,397Mar 04 06:08 PM
Kaplan JohanneChief Development OfficerFeb 19 '26Buy15.351,62925,0053,941Feb 23 08:31 AM
ABG Management Ltd.10% OwnerFeb 03 '26Buy12.13700,7418,499,988943,090Feb 05 07:00 PM

News

latest 14 of 190
  • ProMIS Neurosciences to Participate in Upcoming Conferences in November (GlobeNewswire)
  • ProMIS Heads Into Q3 Report With Shares Down 78% And Cash Runway In Focus (Earnings Whispers)
  • ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026 (GlobeNewswire) +13.67%
  • ProMIS Neurosciences Appoints Seasoned Alzheimer's and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer (GlobeNewswire)
  • ProMIS Neurosciences to Participate in Upcoming Conferences and Events in September (GlobeNewswire)
  • Loading…
  • ProMIS Neurosciences Inc (PMN) (Q2 2026) Earnings Call Highlights: Zero ARIA-E Cases and ... (GuruFocus.com)
  • ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights (GlobeNewswire)
  • ProMIS Neurosciences to Report Second Quarter 2026 Financial Results and Business Update on August 13, 2026 (GlobeNewswire)
  • ProMIS Neurosciences Shares Climb on Positive Interim Alzheimer's Trial Safety Results (InvestorsHub) +23.89%
  • ProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer's Disease Trial (GlobeNewswire)
  • ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer's Disease (GlobeNewswire)
  • ProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026 (GlobeNewswire) +6.72%
  • ProMIS Neurosciences to Participate in Upcoming Conferences in June (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12--1.278--0.006
2026Q22026-08-13-1.280-1.379-1.2800.000.007
2026Q12026-05-12-1.260-1.060-1.2630.00-1
2025Q42026-03-25-4.110-4.660-4.9590.000.003
2025Q32025-11-12-6.000-7.250-5.9280.000.002
2025Q22025-08-13-7.250-4.348-7.2570.000.004
2025Q12025-05-12-5.250-3.000-5.2710.000.001
2024Q42025-03-313.000-3.500-0.1820.000.002
2024Q32024-11-147.750-1.7087.7130.00-1
2024Q22024-08-08-3.250-3.500-3.318--1
2024Q12024-05-14-4.750--4.6520.00--
2023Q42024-04-01-0.750-4.133-4.740--1
2023Q32023-11-14-4.750-8.305-4.771--1
2023Q22023-08-14-6.750--6.7370.00--
2023Q12023-05-15-14.500--14.452---
2022Q32022-11-14-21.250--20.697---

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-31.7185.710-32.1840.007.58
2020FY-23.755--22.1760.00-
2021FY-23.298--40.6190.01-
2022FY-60.250-30.705-60.212-0.00
2023FY-26.750-26.413-26.871--
2024FY2.750-1.3752.6250.000.00
2025FY-22.610-18.090-22.6100.000.00
2026FY--5.103--0.00
2027FY--3.668--0.00
2028FY--3.373--0.00
2029FY--4.135--0.00
2030FY--2.960--7.73

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-08-146000.000.000.00
2026Q3S2026-08-136000.000.000.00
2026Q3S2026-07-246000.000.000.00
2026Q3S2026-07-065000.000.000.00
2026Q3S2026-06-264000.000.000.00
2026Q3S2026-06-053000.000.000.00
2026Q3S2026-05-192000.000.000.00
2026Q3S2026-05-151000.000.000.00
2026Q3S2025-11-201000.000.000.00
2026Q3S2025-10-281000.000.000.00
2026Q3S2025-10-271000.000.000.00
2026Q3S2025-10-261000.000.000.00
2026Q3S2025-10-251000.000.000.00
2026Q3S2025-10-241000.000.000.00

Estimate history

EPS, annual-34.669-49.196-32.184-22.176-40.619-60.212-26.8712.625-22.608-13.4334
Period201720182019202020212022202320242025TTM
EPS, quarterly-3.3187.713-0.182-5.271-7.257-5.928-4.959-1.263-1.283
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.00800.0010.0010.01300000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.1470.1650.1840.1930.2880.3430.7551.3082.1528.968
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.7581.3081.3081.3081.3082.1522.1528.9688.968
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.000.000.000.010.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.020.01----
Gross Profit0.000.000.00-0.02-0.01----
Selling, General and Administrative Excl. Other43.4340.1716.8314.2423.378.474.235.547.86
Research and Development35.6633.3810.647.8816.094.992.363.565.72
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-43.43-40.17-16.83-14.26-23.38-8.50-4.24-5.55-7.87
Interest Expense0.000.000.080.200.280.420.000.000.00
Unusual Expense-0.01-0.01-22.58-0.87-5.480.650.00--
Net Income Before Taxes-42.23-39.722.78-13.21-18.06-9.40-4.22-5.57-7.84
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-42.23-39.722.78-13.21-18.06-9.40-4.22-5.57-7.84
Net Income From Continuing Operations-42.23-39.722.78-13.21-18.06-9.40-4.22-5.57-7.84
Net Income-42.23-39.722.78-13.21-18.06-9.40-4.22-5.57-7.84
EPS (Recurring)-4.62-22.61-12.31-28.10-72.98-38.66-22.17-32.18-49.19
EPS (Basic, Before Extraordinaries)-13.43-22.612.68-26.87-60.21-40.62-22.18-32.18-49.20
EPS (Diluted)-13.43-22.612.63-26.87-60.21-40.62-22.18-32.18-49.20
EBITDA-43.43-40.17-16.83-14.24-23.37-8.46-4.23-5.54-7.86
Non-Operating Income (Expense)1.200.44-2.900.380.120.170.02-0.030.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.000.860.830.270.490.450.310.490.83
Price To Sales Ratio-----3,020.8817,771.1638,143.12129,841.62
Operating Margin------64,976.26-318,186.17-612,381.14-
Net Margin------71,811.94-316,934.42-615,242.81-
Shares Outstanding8.972.151.310.760.340.290.190.180.16
Market Capitalization35.6935.6930.9821.3031.2349.1724.0236.6349.10

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.000.00
Gross Profit0.000.000.000.000.000.000.000.00
Selling, General and Administrative Excl. Other12.278.6410.7711.7510.187.466.004.43
Research and Development9.526.979.379.808.755.464.322.56
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-12.27-8.64-10.77-11.75-10.18-7.46-6.00-4.43
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.00-0.010.000.000.00-5.57-16.97
Net Income Before Taxes-11.73-8.24-10.67-11.58-10.12-7.35-0.249.28
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-11.73-8.24-10.67-11.58-10.12-7.35-0.249.28
Net Income From Continuing Operations-11.73-8.24-10.67-11.58-10.12-7.35-0.249.28
Net Income-11.73-8.24-10.67-11.58-10.12-7.35-0.249.28
EPS (Recurring)-1.28-1.26-4.96-5.93-7.26-5.27-3.16-2.16
EPS (Basic, Before Extraordinaries)-1.28-1.26-4.96-5.93-7.26-5.27-0.187.72
EPS (Diluted)-1.28-1.26-4.96-5.93-7.26-5.27-0.187.71
EBITDA-12.27-8.64-10.77-11.75-10.18-7.46-6.00-4.43
Non-Operating Income (Expense)0.540.400.090.170.070.110.20-3.26
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.410.190.200.200.210.250.620.12
Shares Outstanding8.978.972.152.151.311.311.311.31
Market Capitalization35.6927.3414.6922.8715.8122.7430.9840.86

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.1513.3212.635.9117.010.841.311.781.38
Short Term Receivables0.040.080.080.070.050.030.060.040.04
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets2.965.510.710.930.690.100.190.310.26
Total Current Assets9.1518.9113.426.9017.750.971.562.131.68
Net Property, Plant & Equipment0.000.000.000.000.000.080.000.000.00
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Intangible Assets0.000.000.000.020.030.030.040.040.05
Deferred Tax Assets0.00--------
Other Assets0.030.000.200.000.000.000.000.000.00
Total Assets9.1818.9113.626.9217.781.091.602.171.73
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.000.000.000.00
Accounts Payable2.540.000.000.000.410.441.130.520.21
Other Current Liabilities7.872.229.356.410.521.450.170.800.30
Total Current Liabilities10.412.229.356.410.931.881.291.330.51
Long Term Debt0.000.000.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.030.200.521.8610.930.000.000.000.00
Total Liabilities10.442.429.878.2711.861.881.291.330.51
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity-1.2616.493.75-1.355.92-0.800.310.851.22
Total Shareholders Equity-1.2616.493.75-1.355.92-0.800.310.851.22
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity-1.2616.493.75-1.355.92-0.800.310.851.22
Total Liabilities & Stockholders Equity9.1818.9113.626.9217.781.091.602.171.73
Book Value Per Share-0.5812.614.97-3.9320.56-4.131.675.148.34
Tangible Book Value Per Share-0.5812.614.97-3.9920.47-4.301.474.908.01
Full-Time Employees11777-----
Price to Book Ratio0.721.883.1542.798.31-30.12119.3158.0017.89
Return on Assets-282.7617.08-128.63-146.22-99.63-314.32-295.65-401.83-377.94
Return on Equity-521.6127.46-1,098.51-790.27-367.06--966.39-757.74-727.18
Return on Invested Capital-16.85-352.02--158.80--1,815.58-926.56-378.97
Quick Ratio0.888.521.441.0819.070.521.211.613.31
Current Ratio0.888.521.441.0819.070.521.211.613.31

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-41.91-39.722.78-13.21-18.06-9.40-4.22-5.57-7.84
Depreciation--0.000.020.010.050.010.010.01
Other Funds (Non Cash)0.980.85-18.23-0.60-4.391.500.310.490.83
Funds from Operations-40.93-38.87-15.45-13.79-22.44-7.86-3.90-5.08-7.01
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.9810.75-11.732.945.40-1.590.650.490.34
Cash from Operating Activities-41.90-28.12-27.18-10.84-17.03-9.44-3.25-4.59-6.67
Capital Expenditures0.000.000.000.00-0.00-0.01-0.080.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.100.000.000.00
Purchase or Sale of Investments-0.00-0.00-0.00-0.000.000.00-0.00-0.00-0.00
Purchase of Investments-0.03-0.03-0.03-0.03-0.03-0.03-0.03-0.03-0.03
Sale Or Maturity of Investments0.030.030.030.030.030.040.030.030.03
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.00-0.00-0.00-0.00-0.000.10-0.08-0.00-0.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock90.7420.9427.8817.756.4925.632.864.047.21
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00-0.470.00
Sale of Common Pref Stock90.7420.9427.8817.756.4925.632.864.517.21
Proceedsfrom Stock Options11.8811.850.190.004.9725.631.224.455.82
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities90.7420.9427.8817.756.4925.632.864.047.21
Exchange Rate Effect--0.00-0.18-0.53----
Net Change in Cash48.84-7.170.696.72-11.0716.28-0.47-0.550.54
Free Cash Flow-41.90-28.12-27.18-10.84-17.04-9.45-3.33-4.59-6.67
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments53.4663.856.1515.434.548.40
Short Term Receivables0.220.240.040.090.030.05
Inventories0.000.000.000.000.000.00
Other Current Assets3.021.532.965.944.945.19
Total Current Assets56.6965.619.1521.469.5113.65
Net Property, Plant & Equipment0.000.000.000.000.000.00
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Deferred Tax Assets--0.00---
Other Assets0.001.800.030.000.000.00
Total Assets56.6967.419.1821.469.5113.65
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable1.791.722.544.210.000.00
Other Current Liabilities5.424.907.878.009.824.06
Total Current Liabilities7.226.6110.4112.219.824.06
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.080.080.030.060.070.12
Total Liabilities7.296.6910.4412.279.894.17
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity49.4060.72-1.269.19-0.389.47
Total Shareholders Equity49.4060.72-1.269.19-0.389.47
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity49.4060.72-1.269.19-0.389.47
Total Liabilities & Stockholders Equity56.6967.419.1821.469.5113.65
Book Value Per Share5.516.77-0.584.27-0.297.24
Tangible Book Value Per Share5.516.77-0.584.27-0.297.24
Full-Time Employees--11---
Price to Book Ratio0.72-21.721.602.49-41.342.40
Return on Assets-127.57-100.21-282.76-127.41-154.36-10.86
Return on Equity-172.30-115.73-521.61-355.80--19.56
Return on Invested Capital-23.74-13.58--126.04--77.58
Quick Ratio7.859.920.881.760.973.36
Current Ratio7.859.920.881.760.973.36

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-11.64-8.24-10.31-11.72-10.42-7.35
Other Funds (Non Cash)0.410.190.190.200.220.25
Funds from Operations-11.23-8.05-10.12-11.52-10.20-7.10
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.95-4.331.071.336.202.18
Cash from Operating Activities-10.28-12.38-9.05-10.19-4.01-4.93
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.00-0.000.000.000.00
Purchase of Investments0.000.00-0.030.000.000.00
Sale Or Maturity of Investments0.000.000.030.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.00-0.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.3370.08-0.2821.270.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.3370.08-0.2821.270.000.00
Proceedsfrom Stock Options0.000.0011.160.720.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.3370.08-0.2821.270.000.00
Net Change in Cash-10.6157.70-9.3311.08-4.01-4.93
Free Cash Flow-10.28-12.38-9.05-10.19-4.01-4.93

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.91%0.3M7.0M59.29K
2026-10-153.50%0.2M7.0M78.74K
2026-09-303.39%0.2M7.0M86.03K
2026-09-153.41%0.2M7.0M88.20K
2026-08-313.75%0.3M7.0M82.39K
2026-08-144.00%0.3M7.0M81.99K
2026-07-313.92%0.3M7.2M84.11K
2026-07-153.26%0.2M7.2M40.02K
2026-06-3011.72%0.2M1.7M34.79K
2026-06-1511.54%0.2M1.7M33.61K
2026-05-2912.02%0.2M1.6M40.25K
2026-05-1510.61%0.2M1.6M45.24K
2026-04-309.05%0.1M1.6M51.80K
2026-04-157.71%0.1M1.8M179.18K
2026-03-319.63%0.2M1.8M174.18K
2026-03-137.57%0.1M1.8M171.75K
2026-02-275.75%0.1M1.8M166.30K
2026-02-137.14%0.1M1.8M164.95K
2026-01-302.80%0.0M0.7M155.03K
2026-01-151.41%0.0M1.4M25.92K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-063Initial statement of beneficial ownership of securities2026-10-05SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-13SCHEDULE 13G/ASEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-05-29S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-208-KCurrent report2026-05-20SEC
2026-05-15SCHEDULE 13GSEC
2026-05-15SCHEDULE 13GSEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-07SCHEDULE 13G/ASEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-22SEC
2026-04-09ARSAnnual report to security holders. 2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11129.50K200
2026-105.25K100
2026-090000
2026-0830.32K100
2026-070000
2026-060000
2026-050000
2026-0445.32K100
2026-03141.22K400
2026-028.52M200
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Jupiter Topco LLC60.06%
Deep Track Capital, LP38.82%
WELLINGTON MANAGEMENT GROUP LLP32.35%
Ally Bridge Group28.82%
Trails Edge Capital Partners, LP25.88%
Woodline Partners LP20.53%
Yu Fan15.32%
SPHERA FUNDS MANAGEMENT LTD.15.13%
Squadron Capital Management LLC15.10%
Ikarian Capital, LLC9.52%

Funds

Fund% owned
Tweedy, Browne International Value Fund2.90%
Fidelity Nasdaq Composite Index Fund0.01%
Old Westbury Small & Mid Cap Strategies Fund0.00%
Avantis International Small Cap Value Fund0.00%
Blackstone Alternative Multi-Strategy Fund-0.02%

OakChart. PMN. Cached 15 minutes.